JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McIntosh, D. B.
Right arrow Articles by Andersen, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McIntosh, D. B.
Right arrow Articles by Andersen, J. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 36, 25227-25236, September 3, 1999


Interaction of Nucleotides with Asp351 and the Conserved Phosphorylation Loop of Sarcoplasmic Reticulum Ca2+-ATPase*

David B. McIntoshDagger and David G. Woolley

From the Department of Chemical Pathology, University of Cape Town Medical School, 7925 Cape Town, South Africa

David H. MacLennan

From the Banting and Best Department of Medical Research, C. H. Best Institute, University of Toronto, Toronto, Ontario M5G 1L6, Canada

Bente Vilsen, and Jens Peter Andersen§

From the Department of Physiology, University of Aarhus, DK-8000 Aarhus C, Denmark

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The nucleotide binding properties of mutants with alterations to Asp351 and four of the other residues in the conserved phosphorylation loop, 351DKTGTLT357, of sarcoplasmic reticulum Ca2+-ATPase were investigated using an assay based on the 2',3'-O-(2,4,6-trinitrophenyl)-8-azidoadenosine triphosphate (TNP-8N3-ATP) photolabeling of Lys492 and competition with ATP. In selected cases where the competition assay showed extremely high affinity, ATP binding was also measured by a direct filtration assay. At pH 8.5 in the absence of Ca2+, mutations removing the negative charge of Asp351 (D351N, D351A, and D351T) produced pumps that bound MgTNP-8N3-ATP and MgATP with affinities 20-156-fold higher than wild type (KD as low as 0.006 µM), whereas the affinity of mutant D351E was comparable with wild type. Mutations K352R, K352Q, T355A, and T357A lowered the affinity for MgATP and MgTNP-8N3-ATP 2-1000- and 1-6-fold, respectively, and mutation L356T completely prevented photolabeling of Lys492. In the absence of Ca2+, mutants D351N and D351A exhibited the highest nucleotide affinities in the presence of Mg2+ and at alkaline pH (E1 state). The affinity of mutant D351A for MgATP was extraordinarily high in the presence of Ca2+ (KD = 0.001 µM), suggesting a transition state like configuration at the active site under these conditions. The mutants with reduced ATP affinity, as well as mutants D351N and D351A, exhibited reduced or zero CrATP-induced Ca2+ occlusion due to defective CrATP binding.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The Ca2+-ATPase of sarcoplasmic reticulum is a 10-transmembrane helix Ca2+/H+ pump that hydrolyzes ATP through transient formation of an aspartyl phosphorylated intermediate (1-4). The phosphorylated aspartate residue (Asp351) and the binding site for MgATP are located in the large cytoplasmic domain of the pump protein, whereas the Ca2+ transport sites are in the membrane domain (5). It is a well documented property of the pump that binding of Ca2+ at the transport sites is required to activate phosphoryl transfer from ATP to Asp351. However, the long range intramolecular interaction between the Ca2+ sites and the nucleotide binding site that triggers formation of a transition state for phosphoryl transfer and the nature of this transition state are not well understood. Electrostatic interactions in the vicinity of the phosphoryl groups of ATP and Asp351 and other catalytic residues may be expected to dominate during ATP binding and in the transition state and possibly drive changes in the transport sites (6). The unphosphorylated Ca2+-ATPase exists in a Ca2+- and pH-dependent equilibrium (7) of several (E1/E2) conformational states (Scheme 1) that appear to interact differently with ATP.
<UP>E2H<SUB>3</SUB> ↔ E2H ↔ E1 ↔ E1Ca ↔ E1Ca<SUB>2</SUB></UP>
<UP><SC>Scheme</SC> 1</UP>
Although in the presence of Mg2+ all of the states indicated in Scheme 1 exhibit rather high affinities for ATP (KD in the range 0.5-20 µM) (8, 9), only the E1Ca2 state is primed for transfer of the gamma -phosphoryl group to Asp351. As counterions to Ca2+ (3), protons bind to the transport sites in place of Ca2+, stabilizing the E2 conformation. The fully protonated E2 form (E2H3 in Scheme 1) is phosphorylated by Pi at Asp351 when the pump works in the reverse mode but cannot be phosphorylated by ATP. Since ATP accelerates Pi binding (10) and dephosphorylation (11), modulates Pi right-left-harpoons  HOH exchange (12), and binds fairly tightly to the vanadate complexed E2 form (13), E2H3 must be able to bind ATP without preventing the access of Pi to Asp351, suggesting that the gamma -phosphoryl group of the bound ATP is at some distance from Asp351 in this conformation, in contrast to the E1Ca2 state. A change in the interaction of bound nucleotide with Asp351 related to enzyme activation by Ca2+ is clearly demonstrated with TNP-8N3-ATP1 that has been covalently attached to Lys492 by light activation (14-16). Tethering the nucleotide still permits Ca2+-dependent hydrolysis in the forward direction of catalysis, proving direct interaction with Asp351, and yet has little effect on Pi-dependent phosphorylation in the absence of Ca2+, showing that the nucleotide, or at least a portion of it, shifts position with respect to the aspartyl residue upon Ca2+ binding.

The phosphorylated aspartate and adjoining residues on the COOH-terminal side, segment 351DKTGTLT357, termed the phosphorylation loop in this study, are highly conserved in P-type ATPases (17), and previous mutational analysis has documented their functional importance (18, 19). Besides Asp351, also Lys352, Thr355, Leu356, and Thr357 are critical to Ca2+ transport as well as phosphorylation (19), and further clarification of the distinct roles of these residues in nucleotide binding, phosphoryl transfer, and long range interaction with the Ca2+ sites may aid understanding of energy transduction in the pump. In this study, we assess the effects on nucleotide binding of mutations to the phosphorylation loop residues that previously were shown to result in severely impaired or inactive pumps (18, 19). ATP binding is measured mainly through inhibition of TNP-8N3-ATP photolabeling of Lys492, which has recently been successfully applied to Ca2+-ATPase mutated in segment 487FSRDRK492 (16). In selected cases where the affinity is extremely high, binding is also measured by a direct filtration assay. In addition, the effects of the mutations on Ca2+ occlusion induced with CrATP are determined. The results show that most of the mutations in the phosphorylation loop affect nucleotide binding and disrupt CrATP-induced Ca2+ occlusion. Our analysis of mutations to Asp351 reveals high intrinsic nucleotide binding energies when the negative charge is removed, particularly in the presence of Mg2+ and Ca2+, i.e. in the E1Ca2 state (KD = 0.001 µM for mutant D351A). These favorable interactions may be utilized to gain the transition state and to provoke conformational changes that communicate with the transport sites.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The mutant Ca2+-ATPase cDNAs used in this study were the same as those described previously (18, 19) but were shuttled to vector pMT2 (20) to obtain higher expression levels in COS-1 cells (18, 21). COS-1 cell microsomes containing expressed wild-type or mutated Ca2+-ATPase were isolated by differential centrifugation 48-72 h after transfection (18). The exogenous Ca2+-ATPase content of the microsomal fraction was assayed with a specific sandwich enzyme-linked immunosorbent assay (21).

The synthesis of [gamma -32P]TNP-8N3-ATP, photolabeling of COS-1 cell microsomes, the inhibition by ATP, quantification of labeled bands by electronic autoradiography ("imaging") following SDS-polyacrylamide gel electrophoresis, curve fitting equations and calculations of the "true" KD(ATP) have been described previously (16, 22). For fitting of the TNP-8N3-ATP labeling data, the Hill equation with or without a linear component was used, and the Hill coefficient was set to 1. The concentration of free Ca2+ was set with 5 mM EGTA and variable amounts of total CaCl2 as calculated according to Fabiato and Fabiato (23) taking the Mg2+ concentration and pH into consideration. CrATP-dependent Ca2+ occlusion was measured as before (16, 24).

Equilibrium ATP binding to mutants D351N and D351A was also measured by filtration. COS-1 cell microsomes (1 µl of stock microsomes in 1 ml; approximately 0.5 pmol of Ca2+-ATPase protein/ml) were incubated with [gamma -32P]ATP, 1 mM [3H]sucrose, and other components as indicated in the Fig. 7 legend for 1 min at 25 °C, and the sample was filtered on Millipore GS 0.22-µm filters under mild vacuum. The radioactivity of the filter was measured by liquid scintillation counting. The wet volume of the filter was determined from the tritium radioactivity (range: 28-42 µl), allowing determination of the radioactivity of unbound nucleotide, which was subtracted from the total 32P cpm to obtain the amount of ATP bound to the microsomes.

The formation of a slowly dissociating CrATP complex with the Ca2+-ATPase in the presence of Ca2+ was followed through the inhibition of [gamma -32P]TNP-8N3-ATP photolabeling. Microsomes containing expressed wild-type or mutated Ca2+-ATPase were incubated at 37 °C with CrATP for up to 1 h. Aliquots were taken at timed intervals and diluted 50-fold into irradiation medium with 0.5 µM [gamma -32P]TNP-8N3-ATP. The samples were irradiated for 1 min and subjected to SDS-polyacrylamide gel electrophoresis, and the radioactivity was quantified by electronic autoradiography as described previously (16).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Twenty-four mutations have previously been introduced into the conserved phosphorylation loop of the Ca2+-ATPase between Ile348 and Thr357 (18, 19). All the mutants with alteration to the aspartic acid residue Asp351 receiving the phosphoryl group during catalysis are inactive, and so are the mutants with alterations to Lys352, even in the case of the most conservative replacement of Lys352 with arginine. Activity is not affected by conservative replacements of Thr355 or Thr357 with serine, but replacement with alanine reduces the Ca2+ transport activity as well as the level of phosphoenzyme. Replacement of Leu356 with isoleucine is without effect on activity, but mutation to threonine inactivates the pump. Hence, these residues (nine mutants in all; see Table I) were selected for the present study of nucleotide binding properties.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Nucleotide binding parameters and CrATP-dependent Ca2+ occlusion of wild-type Ca2+-ATPase and mutants
For nucleotide binding, medium was 25 mM HEPPS/TMAH, pH 8.5, 20% (w/v) glycerol, 1 mM MgCl2, 0.5 mM EGTA. For CrATP-dependent Ca2+ occlusion, medium was 50 mM TES/Tris, pH 7.0, 100 mM NaCl, 5 mM MgCl2, 40 µM 45CaCl2, and 1 mM CrATP.

The assay for nucleotide binding, which is based on specific [gamma -32P]TNP-8N3-ATP photolabeling of Lys492 and nucleotide competition, has been validated previously (16). Results obtained under optimum labeling conditions at pH 8.5 demonstrated that this assay is able to produce highly accurate values for TNP-8N3-ATP and ATP binding affinities of Ca2+-ATPase expressed in COS-1 cell microsomes (16). In assessing the results to be described below, it is furthermore useful to know that TNP-8N3-ATP is a substrate of the Ca2+-ATPase, albeit a slow one, whether untethered or tethered to Lys492 by photolabeling (15, 16). This means that the position of the gamma -phosphoryl group of the bound nucleotide must be similar, although probably not identical, to that of bound ATP.

The concentration dependence of TNP-8N3-ATP photolabeling of wild-type and mutant Ca2+-ATPases at pH 8.5 in the presence of Mg2+ and absence of Ca2+ (presence of EGTA) is shown in Fig. 1A. The data could be fitted satisfactorily to the sum of a simple hyperbolic binding function and a linear component, the latter representing nonspecific labeling as previously explained (16). For most of the mutants, the linear component was small and insignificant, but as seen in Fig. 1 the linear component was rather prominent for mutant K352Q, for unknown reasons. The derived K0.5 values corresponding to the hyperbolic component are listed in Table I. It can been seen that removal of the negative charge on Asp351, as shown by mutants D351N, D351A, and D351T, led to a pronounced increase in TNP-8N3-ATP affinity, with D351N exhibiting the largest increase of 156-fold. By contrast, mutation D351E, which conserves the negative charge, did not significantly affect the TNP-8N3-ATP binding affinity. The concentration of Ca2+-ATPase in the irradiation assay was approximately 0.4 nM for the tightly binding mutants and approximately 2 nM for the rest to ensure a reasonably high ratio of free to bound nucleotide, thereby allowing the total concentration to be equated with the free concentration.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 1.   TNP-8N3-ATP photolabeling (A) and ATP inhibition (B). A, photolabeling was performed in 25 mM HEPPS/TMAH, pH 8.5, 1 mM MgCl2, 0.5 mM EGTA, 20% (w/v) glycerol, the indicated concentrations of [gamma -32P]TNP-8N3-ATP, and a 125-625-fold dilution of stock COS-1 cell microsomes (to 0.4-2 nM Ca2+-ATPase). The samples were subjected to SDS-polyacrylamide gel electrophoresis, and the relevant radioactive bands were quantified by imaging. The data were fitted to the sum of a hyperbolic function and a linear function, the latter representing nonspecific labeling, and the derived K0.5 values for the hyperbolic function are shown in Table I. B, experiments were performed as above at a concentration of TNP-8N3-ATP of 3 × K0.5 for each mutant Ca2+-ATPase (see Table I), except for T357A and K352Q, where it was equal to the K0.5, and ATP was included at the concentrations shown. In two cases, namely mutations K352Q and T357A, additional Mg2+ was included at 1 and 3 mM ATP to a total concentration of 2 and 4 mM, respectively. The data were fitted to a simple binding function with an offset representing nonspecific labeling. The KD(ATP) values calculated from the derived K0.5 values as described (16) are listed in Table I. down-triangle, wild type; black-diamond , D351N; triangle , D351T; , D351A; open circle , D351E; black-triangle, K352R; black-square, K352Q; , T355A; diamond , T357A.

Mutation K352Q, which removes the positive charge of Lys352, lowered the affinity for TNP-8N3-ATP at least 5-fold, whereas the more conservative replacement with arginine, K352R, was without significant effect. Mutation T355A was likewise silent, but T357A lowered the affinity for the TNP nucleotide about 6-fold. Mutant L356T exhibited a low level of labeling that was linear with increasing concentrations of TNP-8N3-ATP up to 30 µM. This indicates that either Lys492 was not being labeled or the affinity was extremely poor (K0.5 estimated to be >50 µM).

The inhibition of photolabeling by ATP under the same buffer conditions is shown in Fig. 1B, and the derived true KD values assuming competitive inhibition are listed in Table I. Usually, the concentration of TNP-8N3-ATP was fixed at 3 × K0.5 to ensure that the binding site is close to saturation; however, in the case of mutants K352Q and T357A, inhibition was so poor at these concentrations that the TNP-8N3-ATP concentrations were lowered to the K0.5 in each case. It is apparent that removal of the negative charge on Asp351 caused a large increase in affinity for ATP (83-fold, 45-fold, and 22-fold for D351N, D351T, and D351A, respectively) similar to that seen for TNP-8N3-ATP. Mutations D351E and T355A appeared to slightly decrease the affinity for ATP (1.5-2-fold compared with wild type). While mutation K352R resulted in a 13-fold reduction of ATP affinity, K352Q led to a spectacular effect, reducing the ATP affinity close to 1000-fold. Mutation T357A decreased the affinity for ATP at least 40-fold. Because the affinity of the latter two mutants was too low for complete inhibition to be reached, the choice of the offset of the binding curve was somewhat uncertain in these cases, resulting in corresponding uncertainties with respect to the exact KD(ATP) values.

Hence, the results shown in Fig. 1 indicate that the most disruptive mutation in terms of nucleotide binding is L356T, followed by K352Q, T357A, and K352R. The latter three mutations affected ATP binding much more than the binding of TNP-nucleotide, similar to the situation with mutations close to Lys492 (16). All of the mutants in which the negative charge on Asp351 was removed exhibited a large increase in affinity for both nucleotides, with D351N being the most dramatic. On the other hand, mutation D351E had little effect on the binding of either nucleotide.

Nucleotide binding and the coupling between the catalytic and transport sites can be assessed by measuring CrATP-induced Ca2+ occlusion. CrATP slowly forms a complex with the Ca2+-ATPase at the catalytic site without phosphorylating Asp351 and causes simultaneous occlusion of Ca2+ at the transport sites (24-27). Because this complex is very stable, requiring hours to dissociate, 45Ca2+ occlusion with CrATP can be measured in Ca2+-ATPase expressed in COS-1 cell microsomes by size exclusion HPLC following detergent solubilization of the microsomes (24). The results of such measurements on the wild type and selected mutants are shown in Fig. 2 and summarized in Table I. The microsomes were incubated 1 h at 37 °C with 1 mM CrATP and 40 µM 45Ca2+, i.e. just about enough to ensure saturation of the occlusion reaction in the wild-type enzyme, before solubilization and chromatography. Equal amounts of expressed Ca2+-ATPase, according to enzyme-linked immunosorbent assay measurements, were chromatographed, so the elution profiles are comparable. The control represents microsomes without expressed Ca2+-ATPase, i.e. harvested from COS-1 cells mock-transfected with the expression vector without insert. The amount of control microsomes in mg of total membrane protein corresponds to that chromatographed in the case of the wild type. The distinct peak of radioactivity eluting between 14 and 15 min in the experiment with the wild type and in some of the experiments with mutants represents Ca2+ occluded in the detergent-solubilized monomeric enzyme (24). As can be seen, there was no such peak for mutants D351N and D351A, and hence these mutants did not occlude Ca2+. Mutants K352R and T355A showed partial occlusion, and mutants K352Q, L356T, and T357A also failed to occlude Ca2+.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 2.   CrATP-dependent Ca2+ occlusion. Occlusion of Ca2+ by wild-type or mutant Ca2+-ATPase expressed in COS-1 cell microsomes was measured following incubation for 1 h at 37 °C in 50 mM TES/Tris, pH 7.0, 100 mM NaCl, 5 mM MgCl2, 40 µM 45CaCl2, and 1 mM CrATP. The graphs show the size exclusion HPLC elution profiles of 45Ca associated with solubilized protein originating from microsomes harvested from cells transfected with wild-type or mutant Ca2+-ATPase cDNA and from control microsomes from cells transfected with the expression vector without insert. The difference between the test and control curves corresponding to the elution time of the monomeric Ca2+-ATPase at 14-15 min provides a measure of the occluded Ca2+. Equivalent amounts of wild-type and mutant Ca2+-ATPase protein (as determined by enzyme-linked immunosorbent assay) were applied to the column in the experiments shown. A summary of the results is shown in Table I.

Thus, for some mutations, notably those that slightly or grossly lower the affinity for ATP, the effect on CrATP-induced Ca2+ occlusion seems to be correlated with the change in ATP binding affinity. However, mutations to Asp351, which caused a huge increase in affinity for ATP, also appeared to prevent CrATP-induced Ca2+ occlusion. In order to elucidate whether this was due to defective CrATP complexation at the catalytic site or an uncoupling of CrATP complexation and Ca2+ occlusion, we devised an assay wherein the microsomes were incubated with CrATP for up to 1 h at 37 °C and then diluted substantially prior to photolabeling with TNP-8N3-ATP. The affinity of the Ca2+-ATPase for CrATP is not high, and a concentration of CrATP in the millimolar range is required to obtain saturation so that occlusion occurs in a reasonable period of time. To minimize the competitive binding of contaminant ATP that might be present in the CrATP preparation, the samples were irradiated under conditions where the affinity for TNP-8N3-ATP is reasonably high and that for ATP is fairly low (pH 8.5 in the presence of EDTA). Also with this in mind, a concentration of TNP-8N3-ATP of approximately 10× K0.5 was chosen. As seen in Fig. 3, photolabeling of the wild-type Ca2+-ATPase was inhibited by CrATP in a time-dependent manner, indicative of a gradual and effectively irreversible complexation of CrATP at the catalytic site. In mutants D351N and D351A, CrATP failed to inhibit photolabeling, showing that the irreversible binding of CrATP had not occurred. This explains the lack of CrATP-induced Ca2+ occlusion in these mutants.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 3.   CrATP inhibition of TNP-8N3-ATP photolabeling. The microsomes were incubated at 37 °C in 50 mM MOPS/TMAH, pH 7.0, 100 mM NaCl, 2 mM MgCl2, 0.1 mM CaCl2, and without (open symbols) or with (solid symbols) 1 mM CrATP. At the indicated times, aliquots were diluted 50-fold into irradiation medium containing 25 mM HEPPS/TMAH, pH 8.5, 2 mM EDTA, 20% (w/v) glycerol, and 0.5 µM [gamma -32P]TNP-8N3-ATP. The samples were irradiated and subjected to SDS-polyacrylamide gel electrophoresis, and the radioactivity was quantified. Circles, wild type; squares, D351N; triangles, D351A.

The buffer conditions in the above binding experiments with TNP-8N3-ATP and ATP (pH 8.5, in the presence of Mg2+ and absence of Ca2+) largely favor accumulation of the E1 state of the wild-type Ca2+-ATPase, whereas the E2H and E2H3 forms (cf. Scheme 1) would predominate at neutral and acid pH in the absence of Ca2+ (7). To better understand the huge increase in nucleotide affinity induced by mutations D351N and D351A and the implications for the catalytic mechanism, we investigated the influence of pH, Mg2+, and Ca2+, as well as thapsigargin, a tightly binding inhibitor that appears to lock the enzyme into E2 or an "E2-like" state (28). Results of these studies are presented in Figs. 4-6 and summarized in Table II in terms of derived dissociation constants.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 4.   Photolabeling (A) and inhibition by ATP (B) of wild-type Ca2+-ATPase at pH 7.0. Photolabeling was performed as in Fig. 1 except that the buffer was MOPS, pH 7.0. Additional MgCl2 was added at high ATP concentrations as in Fig. 1. The dashed line in A shows the curve obtained after subtraction of the linear component. The insets show portions of the autoradiographs of the SDS-polyacrylamide gels at the level of the expressed wild-type Ca2+-ATPase. In A, there are 10 lanes with concentrations of TNP-8N3-ATP as follows: 0.03, 0.1, 0.3, 0.6, 1, 3, 6, 10, 20, and 30 µM; in B, there are also 10 lanes with concentrations of ATP of 0, 0.3, 1, 3, 10, 30, 100, 300, 1000, and 3000 µM.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of Mg2+ and Ca2+ on TNP-8N3-ATP photolabeling (A and B) and ATP inhibition (C and D) of mutant D351N at pH 7.0 (A and C) and pH 8.5 (B and D). Photolabeling was performed as in Figs. 1 and 4, in the presence of 1 mM MgCl2 + 0.5 mM EGTA (open circle ), 2 mM EDTA (triangle ), or 1 mM MgCl2 plus 0.05 mM CaCl2 ().


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 6.   Effect of Mg2+ and Ca2+ on TNP-8N3-ATP photolabeling (A and B) and ATP inhibition (C and D) of mutant D351A at pH 7.0 (A and C) and pH 8.5 (B and D). Photolabeling was performed as in Figs. 1 and 4, in the presence of 1 mM MgCl2 plus 0.5 mM EGTA (open circle ), 2 mM EDTA (triangle ), or 1 mM MgCl2 plus 0.05 mM CaCl2 ().

                              
View this table:
[in this window]
[in a new window]
 
Table II
Effect of Mg2+, Ca2+, pH, and thapsigargin on nucleotide binding parameters of wild-type Ca2+-ATPase and mutants D351N and D351A

As previously noted (16), the efficiency of the specific incorporation of TNP-8N3-ATP photolabel into the Ca2+-ATPase expressed in COS-1 cell membrane is almost as high at neutral pH compared with alkaline pH, contrary to the situation for Ca2+-ATPase in sarcoplasmic reticulum. This made it feasible to extend the photolabeling assay to pH 7.0 for the expressed wild-type and mutant Ca2+-ATPases. The TNP-8N3-ATP concentration dependence of photolabeling of the wild-type Ca2+-ATPase at pH 7.0 in the presence of Mg2+ is shown in Fig. 4A. The concentration dependence is characterized by hyperbolic and linear phases, with the specific hyperbolic component dominating in the low concentration range. This is similar to the results obtained at pH 8.5 (see Ref. 16 for a detailed description of the wild-type data at pH 8.5). The inset shows autoradiographs of the same experiments, and it can be seen that even at pH 7.0 the ratio of Ca2+-ATPase labeling to background labeling is reasonably high. The inhibition by ATP of the photolabeling of the wild type at pH 7.0 in the presence of a concentration of TNP-8N3-ATP of 3 × K0.5 is shown in Fig. 4B. Similar experiments at pH 7.0 were performed in the absence of Mg2+ (in the presence of 2 mM EDTA), the amount of extra labeling in the 10-30 µM range being much less in this condition (data not shown). In addition, experiments in the absence of Mg2+ were carried out at pH 8.5 for comparison. As seen in Table II, the decrease in pH from 8.5 to 7.0 enhanced the affinity of the wild-type Ca2+-ATPase for TNP-8N3-ATP 2-fold in the presence of Mg2+, whereas the affinity for ATP was reduced 16-fold under these conditions. The effects of Mg2+ were also quite different for the two nucleotides, the divalent cation strongly enhancing ATP binding (33-fold at pH 8.5 and 9-fold at pH 7.0) but diminishing the affinity for TNP-8N3-ATP, especially at pH 8.5. A trend to higher affinity for ATP in the presence of Mg2+ and at alkaline pH has previously been reported for the Ca2+-ATPase in the native sarcoplasmic reticulum membrane (9, 29, 30), although the effects appear to be somewhat larger in the present study, possibly because of the presence of glycerol (31), which is added as a nitrene scavenger.

As seen in Figs. 5 and 6 and Table II, the observation of higher nucleotide affinities of mutants D351N and D351A relative to wild type could be confirmed at pH 7.0 as well as in the absence of Mg2+, although the pH and Mg2+ influenced to some extent the magnitude of the affinity increase induced by the mutations. At pH 8.5, the mutations seem to negate the anomalous inhibitory effect of Mg2+ on TNP-8N3-ATP binding to wild-type Ca2+-ATPase, the divalent cation actually enhancing the affinity 2-3-fold in the case of D351N and having no significant effect for mutation D351A. The Mg2+-induced enhancement of ATP affinity was even more pronounced in mutant D351N (200-fold) than in the wild type at pH 8.5 but was much less (only 2-fold) at pH 7.0.

It was previously demonstrated that thapsigargin is without effect on TNP-8N3-ATP photolabeling of the wild-type Ca2+-ATPase but lowers the affinity for ATP more than 100-fold (16). In the presence of thapsigargin, both of the mutants D351N and D351A displayed much lower affinity for either nucleotide than in the absence of the inhibitor (Table II), but the effect of the inhibitor was most pronounced for ATP (more than 700-fold decrease in ATP affinity of both mutants). Importantly, even in the thapsigargin-bound state, the mutations induced a significant increase in affinity for both nucleotides. Since thapsigargin is believed to stabilize E2 or an "E2-like state" (28), this finding clearly demonstrates that the affinity increase resulting from removal of the negative charge of Asp351 is not an exclusive property of E1 forms. On the other hand, it is noteworthy that the magnitudes of the effects induced by the mutations were somewhat smaller in the presence of thapsigargin than in its absence (cf. also Table III and below).

                              
View this table:
[in this window]
[in a new window]
 
Table III
Nucleotide/Asp351 interaction energies

Because Ca2+ binding to the transport sites on the wild-type Ca2+-ATPase activates rapid transfer of the gamma -phosphoryl group of bound ATP to the enzyme, the affinity of the wild-type enzyme for ATP in the presence of Ca2+ cannot be determined under equilibrium conditions, but a value of 3 µM for the KD(ATP) of the wild-type enzyme in the presence of Ca2+ has been estimated on the basis of rapid kinetic measurements of association and dissociation rate constants (8). The inability of mutants D351N and D351A to phosphorylate offered a unique possibility for studies of the effect of Ca2+ on equilibrium ATP binding to these mutants. As seen in Figs. 5 and 6 and Table II, we determined the affinities for TNP-8N3-ATP as well as ATP in the presence of Mg2+ and Ca2+ at both pH 8.5 and pH 7.0. For mutant D351N, Ca2+ binding caused a significant 4-fold reduction of the affinity for ATP at pH 8.5, whereas, surprisingly, at pH 7.0 the affinities for both nucleotides were increased (10-fold for TNP-8N3-ATP and 20-fold for ATP). For mutant D351A, Ca2+ binding caused a tremendous increase in ATP affinity, resulting in a KD of about 0.001 µM at both pH values (300-fold increase in affinity at pH 7.0 and 23-fold at pH 8.5). Also, the affinity for the TNP-nucleotide increased very much in the presence of Ca2+ in this mutant (10-fold at pH 8.5 and 40-fold at pH 7.0).

The important implications of these Ca2+-dependent changes in ATP binding and the extremely high affinities for ATP prompted us to try to verify the photolabeling results by measuring ATP binding directly by filtration. This method is not generally applicable to expressed wild-type or mutant proteins, since each data point requires several µg of protein when the KD is in the micromolar range or above, and also there could be a problem with the specificity under these conditions considering the large number of proteins in the COS cell microsomes. Fig. 7 shows the results obtained at pH 7.0, and as can be seen extremely tight [gamma -32P]ATP binding to mutants D351A and D351N could indeed be measured in the presence of Ca2+. The KD values (0.0012 and 0.030 µM, respectively) are the same or very similar to those found by photolabeling (0.0014 and 0.028 µM, respectively). The binding in the absence of Ca2+ was much weaker, and the data points are compatible with the KD values obtained by photolabeling (0.42 and 0.57 µM, respectively, Table II). It could be noted that the filtration experiments were performed in the absence of glycerol, and the similarity of the photolabeling and filtration measurements indicates that the cosolvent is not affecting the KD values significantly under these conditions. Using the filtration assay, we also obtained a few data points at pH 8.5, confirming that the addition of Ca2+ increases the ATP affinity of mutant D351A and decreases the ATP affinity of mutant D351N (results not shown).


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 7.   ATP binding to mutants D351N (closed symbols) and D351A (open symbols) determined by filtration. Binding of [gamma -32P]ATP was measured with 0.5-0.6 pmol of Ca2+-ATPase in 50 mM MOPS/TMAH, pH 7.0, 1 mM MgCl2, 1 mM [3H]sucrose, either 0.1 mM CaCl2 (circles) or 1 mM EGTA (triangles), and variable concentrations of [gamma -32P]ATP as indicated. The duplicate data points at each concentration of ATP were from separate experiments performed on different days. The data points in the presence of Ca2+ were fitted to the Hill equation with the Hill coefficient set to 1 and yielded KD values of 0.030 and 0.0012 µM for mutants D351N and D351A, respectively. Similar KD values were obtained on two different preparations of mutants D351N and D351A.

The increase in the affinity for TNP-8N3-ATP upon Ca2+ binding to the transport sites of mutants D351N and D351A at pH 7.0 (10- and 40-fold, respectively) permitted investigation of the Ca2+ concentration dependence of this phenomenon (Fig. 8). While the Hill coefficients of 1.3 are similar to those observed for Ca2+ binding to the wild-type Ca2+-ATPase in sarcoplasmic reticulum, the K0.5 values of 0.10 and 0.05 µM for mutants D351N and D351A, respectively, are more than 10-fold lower than those determined for sarcoplasmic reticulum Ca2+-ATPase under comparable buffer conditions by equilibrium binding studies in the absence of nucleotide or in the presence of nonhydrolyzable nucleotides such as AMPPCP (32, 33).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 8.   Ca2+ dependence of TNP-8N3-ATP photolabeling of mutants D351N () and D351A (open circle ) at pH 7.0. Photolabeling was performed as in Fig. 1 except that the buffer contained 150 mM MOPS (pH 7.0), 5 mM EGTA, and variable calcium concentrations to yield the free Ca2+ concentrations shown. The concentration of [gamma -32P]TNP-8N3-ATP was 10 and 30 nM for mutants D351N and D351A, respectively. The data were fitted to the Hill equation and offset (mutant D351N: K0.5 = 0.10 µM, nH = 1.3; mutant D351A: K0.5 = 0.05 µM, nH = 1.3).

For nondisruptive mutations, the interaction energies (Delta Delta GInteraction) between a side chain and ligand can be obtained from the ratio of the dissociation constants of wild type and mutant proteins (34). Table III shows the results of such calculations of nucleotide-Asp351 interaction energies for mutants D351N and D351A based on the data in Table II for wild type and mutants in the absence of Ca2+ and some additional results of similar studies with ADP and AMPPCP in place of ATP (see below). The interaction energies for ATP in the presence of Ca2+ and Mg2+ were also calculated for pH 7.0 (last line in Table III) using the data in Table II for the mutants and the KD(ATP) of 3 µM for the wild type determined by rapid kinetic measurements (8). In the absence of Ca2+, the interaction energies calculated for mutation D351N tend to be higher than those calculated for mutation D351A. The TNP-8N3-ATP data show no pH dependence in the absence of Mg2+ but a strong dependence in its presence. Thus, for both mutants there is a pronounced Mg2+-induced increase in the interaction energy at pH 8.5, but not at pH 7.0. Thapsigargin binding at pH 8.5 has a similar effect to lowering the pH or removing the divalent cation. As for the ATP data, the interaction energy calculated for mutant D351N appears to follow the general trend, being enhanced from 1.6 to 2.6 kcal/mol by Mg2+ at pH 8.5 and by the pH increase in the presence of Mg2+, whereas the interaction energy calculated for mutant D351A remains close to the lower of these two values, unaffected by Mg2+ and pH. Ca2+, on the other hand, seems to increase the interaction energy most strongly for mutant D351A, to as much as 4.5 kcal/mol.

The KD values determined for the binding of ADP and AMPPCP at pH 8.5 in the presence of Mg2+ were for the wild type 7 and 63 µM, respectively, and for mutant D351N 0.23 and 0.8 µM, respectively (data not shown, but see the derived interaction energies in Table III). Thus, the interaction energy with MgADP is lower than with MgATP but still significant. The energy with MgAMPPCP is similar to MgATP.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Our results document the close interaction of bound nucleotides with Asp351 and other residues in the conserved phosphorylation loop of sarcoplasmic reticulum Ca2+-ATPase. Elimination of the charge on Asp351, as in mutations D351N, D351A, and D351T, enhanced the affinity for ATP and TNP-8N3-ATP up to 156-fold in the absence of Ca2+ and even more in the presence of Ca2+, suggesting strong electrostatic effects between the gamma -phosphate and the aspartate in the wild-type pump. In contrast, fairly conservative changes to Lys352, Thr355, Leu356, and Thr357 impaired nucleotide binding to various extents, suggesting that these residues either directly ligate nucleotide or influence those that do. The removal of the positive charge of Lys352 in mutant K352Q gave rise to a very pronounced decrease in ATP affinity of at least 1000-fold, again revealing the importance of electrostatic interactions at the active site. The disruptive mutations, as well as D351N and D351A, reduced or eliminated CrATP-induced Ca2+ occlusion.

Recently, bacterial haloacid dehalogenases have been found to be homologous with P-type ATPases (35), and the crystal structures of the dehalogenases provide insights into possible Ca2+-ATPase structure. A catalytic aspartate of the dehalogenases is homologous to Asp351 of Ca2+-ATPase and is positioned at the end of a beta -strand, which is centrally located in a beta -sheet (36). The critical aspartate leads into a spiral loop and hence to a secondary domain, which acts like a cap over the aspartate and active site. In the Ca2+-ATPase, the nucleotide substrate must be positioned between the two domains, but it is not yet clear how it would be oriented with respect to the aspartate and the phosphorylation loop. Crude modeling suggests that Lys352 may be involved in direct interaction with the nucleotide, and the disruptive influence of even K352R on ATP binding is compatible with a role for this lysine in direct ligation. Leu356 and Thr357 do not appear to be able to interact directly with the nucleotide but rather appear to brace Asp351 and Lys352 and lead into the hinge segment between the main phosphorylation domain and the secondary cap domain. Mutation L356T was severely disruptive and seemed to prevent photolabeling of Lys492 (expected to be part of the cap domain and some distance away from Leu356). If this is occurring by shifting the position of Lys492, it would indicate interdomain communication between critical regions of the protein and point to Leu356 being in a pivotal position. Alternatively, the nucleotide affinity may have been reduced as a result of displacement of Asp351 and Lys352. Thr355 appears to play a minor role in ATP binding, and perhaps the ATP molecule is oriented away from this residue, and its apparently crucial role in phosphorylation (19) may be catalytic, a conclusion supported by the strong conservation of this residue in both P-type pumps and dehalogenases (35).

Mutations D351N, D351A, and D351T generally caused large increases in affinity for TNP-8N3-ATP and ATP, suggesting the existence of a strong electrostatic repulsion between the aspartate and the gamma -phosphoryl group of ATP, which obscures a high intrinsic binding energy. These results are in line with the findings of Pedersen et al. (6) on renal Na+,K+-ATPase, which demonstrated increases of up to 39-fold in the absence of Mg2+ following mutation of the equivalent aspartate (Asp369) to alanine. We obtained increases of 17- and 66-fold for mutations D351A and D351N, respectively, under comparable conditions at pH 7.0 in EDTA. In many of the conditions tested, we found larger affinity increases for the asparagine substitution than for the alanine substitution, in contrast to what was found for the Na+,K+-ATPase, where the alanine substitution appears to be the more effective. It may furthermore be noted that the Na+,K+-ATPase D369N mutant showed no significant change (or possibly a slight decrease) in affinity for ADP relative to the wild type, whereas a 30-fold increase in affinity for MgADP was demonstrated for the corresponding Ca2+-ATPase mutant. This difference may possibly be ascribed to the presence of Mg2+ (see below).

The results obtained with mutant D351N in the absence of Ca2+ reveal that the increase in nucleotide affinity induced by the mutation (nucleotide-Asp351 interaction energies, Delta Delta GInteraction, Table III) is largest at alkaline pH in the presence of Mg2+. Mg2+ increases the interaction energy (or electrostatic repulsion) between the gamma -phosphoryl group and Asp351 at pH 8.5 but has little effect at pH 7.0. Since the E1 form of the pump is expected to prevail at pH 8.5, whereas the E2H and E2H3 forms accumulate at pH 7.0 when Ca2+ is absent (7), our data suggest that the Mg2+ effect depends on the enzyme being in the E1 form.

ATP has two negative charges on the gamma -phosphoryl group at pH 8.5 and is partially protonated at pH 7.0 (pKa = 6.63), whereas MgATP can be expected to have a single negative charge at both pH values (pKa = 4.72) (37). Mg2+ might have been expected to decrease the electrostatic interaction at both pH values. Also, Mg2+ is expected to polarize the P-O bond, withdrawing electronegativity from the phosphorus atom, which should further reduce the repulsion. But these ameliorating effects of Mg2+ appear to be counteracted by an increased binding interaction and a rise in repulsion as reflected in the change in interaction energy from 1.6 kcal/mol to 2.6 kcal/mol, resulting from Mg2+ binding at pH 8.5 in the case of mutant D351N. This is probably the result of Mg2+ assisting a close approach of the gamma -phosphoryl group and the carboxylate anion in the E1 state.

In the presence of Mg2+, the decrease in nucleotide-Asp351 interaction energy observed for the D351N mutant when the pH is reduced from 8.5 to 7.0 is roughly equivalent to the decrease seen upon thapsigargin binding or replacement of MgATP with MgADP. This is consistent with the hypothesis that, in the first two instances, the gamma -phosphoryl group is withdrawn 3-4 Å from Asp351, or approximately the length of a phosphate group. Since E2 states are expected to prevail both at the lower pH and in the presence of thapsigargin, the displacement of nucleotide from the phosphorylation loop under these conditions is compatible with other findings that ATP and Pi can bind simultaneously at the active site in E2 states (10-14).

The ATP-Asp351 interaction energy calculated for mutant D351A at alkaline pH in the presence of Mg2+ is similar to the interaction energy calculated for D351N at pH 7.0 in the presence of Mg2+. For mutant D351A, there is furthermore little effect of reducing the Mg2+ concentration or pH. The reason could be that mutation D351A to some extent counteracts the influence of alkaline pH on the E1-E2 conformational equilibrium in the absence of Ca2+. This would be equivalent to the displacement of the equilibrium in favor of E2 reported for the D369A mutation in the Na+,K+-ATPase (6).

A central observation in the present study is that Ca2+ binding to the transport sites causes a substantial increase in the intrinsic nucleotide binding energy of either of the mutants D351N and D351A at pH 7.0 and of D351A at pH 8.5. The same results were obtained both with the photolabeling assay and a direct filtration assay. In the case of mutant D351A at pH 7.0, the affinity for MgATP is increased 300-fold upon Ca2+ binding. The affinity of the wild-type Ca2+-ATPase for MgATP in the presence of Ca2+ cannot be measured directly in equilibrium binding experiments due to the activation of phosphoryl transfer by Ca2+, but it has been estimated from rapid kinetic determinations of association and dissociation rate constants to be very similar to the affinity in the absence of Ca2+ at pH 7.0 (8). The very large increase in MgATP affinity induced by Ca2+ binding in mutant D351A may possibly be ascribed to a close resemblance of the E1Ca2 complex of mutant D351A with MgATP to the transition state for phosphoryl transfer (a "pseudotransition state"), the only difference from the transition state in the wild type being the absence of strong electrostatic effects corresponding to an interaction energy of as much as 4.5 kcal/mol (Table III). The reason why the corresponding complex of mutant D351N is less tight may be that the amino hydrogens of the asparagine impose steric hindrance to the closest possible approach of the gamma -phosphoryl group of ATP, whereas the shorter alanine side chain with attendant void can be accommodated. This would be especially critical in an associative mechanism of phosphoryl transfer (where there is substantial bond formation between the oxyanion of the carboxylate and the phosphorus atom while the bond between the gamma -phosphorus and the bridging oxygen is being broken) compared with a dissociative mechanism (where a distinct metaphosphate intermediate is generated) (see Scheme 2).


View larger version (16K):
[in this window]
[in a new window]
 
Scheme 2.  

In light of the Ca2+ effects on nucleotide affinities described here, it is noteworthy that the ATP affinity of the Na+,K+-ATPase mutant D369A appeared to be unaffected by the presence of Na+ (6), although this cation plays a role as activator of the phosphorylation reaction in Na+,K+-ATPase equivalent to that of Ca2+ in the Ca2+-ATPase. A likely explanation is that the studies on Na+,K+-ATPase mutants were conducted in the absence of Mg2+, which is also required at the catalytic site for transition state formation and, thus, for attainment of the extremely high nucleotide affinity.

The Ca2+ activation of phosphorylation in the wild-type Ca2+-ATPase and of nucleotide binding with very high affinity in the D351A and D351N mutants implies that signals originating in the Ca2+ transport sites in the membrane are conveyed by protein conformational changes over long distance to the catalytic site in the cytoplasmic protein domain. Signals originating at the catalytic site are likewise transmitted in the reverse direction from the cytoplasmic portion down the stalk to the Ca2+ sites (5, 38). Hence, in the wild-type enzyme the phosphorylation of Asp351 (or perhaps already the formation of the transition state) leads to occlusion of Ca2+. The occluded Ca2+ is released from the phosphoenzyme only following conformational changes that open the binding pocket toward the luminal side of the membrane (38, 39). An intriguing question was, therefore, whether mutations D351N and D351A elicited events at the catalytic site that were transmitted to the membrane domain, affecting the Ca2+ binding properties of the transport sites. We tested the affinity for Ca2+ in mutants D351N and D351A by making use of the Ca2+-induced increase in affinity for TNP-8N3-ATP at pH 7.0. The results show that the apparent Ca2+ affinities of the mutants were significantly higher than the literature values for the wild-type Ca2+-ATPase in sarcoplasmic reticulum determined under comparable conditions in the presence or absence of nonhydrolyzable nucleotide (32, 33) and highest in the case of mutation D351A. In our assay for Ca2+ binding (Fig. 8), the concentration of TNP nucleotide present was by necessity only partially saturating for the most part, and therefore the KD values for Ca2+ binding to mutant proteins with bound nucleotide should be even lower than the 0.1 and 0.05 µM indicated by the data in the figure. Also, the "principle of linked functions" (40) resulting from basic thermodynamics predicts that when Ca2+ binding increases the affinity for nucleotide, then nucleotide binding should correspondingly increase the affinity for Ca2+. Hence, the results support the hypothesis that in the pseudotransition state induced by the mutations in the presence of nucleotide, Ca2+ is bound with increased affinity relative to the normal E1 state of the wild-type enzyme.

Incubation of the Ca2+-ATPase with CrATP as substitute for ATP leads to gradual formation of a very slowly dissociating complex with the active site without phosphorylating Asp351, and simultaneously Ca2+ bound at the transport sites becomes stably occluded (24-27). The complex with CrATP may mimic to some extent a pretransition state, the transition state, or the phosphorylated state (38). Our findings with the D351N and D351A mutants seem to suggest that Asp351 is critical for CrATP complexation and, thus, for the accompanying Ca2+ occlusion. The mechanism behind the development of the slowly dissociating complex over time is unknown, but it might involve replacement of the Cr3+-coordinated waters with protein ligands, and if this is the case then the carboxylate of Asp351 appears to be one of these. Caution is needed in interpreting these results, because even traces of ATP present as contaminant in the CrATP preparation might be able to compete efficiently with CrATP for binding to the mutants due to their very high ATP affinity. However, we have not been able to detect any significant level of ATP contamination in the purified CrATP preparation that was used.

In conclusion, the present results seem to support the following ideas concerning the mechanism of catalysis and energy transduction in the initial part of the Ca2+-ATPase reaction cycle. At pH 7.0 and before the binding of Ca2+, MgATP binds fairly tightly such that the nucleotide and Asp351 may be poised electrostatically repelling each other to the extent of approximately 1.6 kcal/mol. Ca2+ binding at the transport sites causes a significant increase in the favorable nucleotide-active site interactions, to the extent of approximately 2.9 (4.5 - 1.6) kcal/mol, which in the wild type may be used to balance an increase in the electrostatic repulsion between the gamma -phosphate and Asp351, thereby facilitating the phosphoryl transfer. The Ca2+-induced conformational change could involve the repositioning of a positively charged residue, such as a lysine, in proximity to the gamma -phosphate and Asp351 to create a salt linkage with the phosphate. This mechanism finds support in the Ca2+-dependent cross-linking of a lysyl residue to Asp351 (41) and the involvement of a lysyl residue in the catalytic mechanism of haloacid dehalogenases (35). In the Ca2+-ATPase, the events at the catalytic site elicit further conformational changes in the Ca2+ binding domain that increase the Ca2+ affinity and bring about occlusion of the Ca2+ sites.

    ACKNOWLEDGEMENTS

We thank Karin Kracht and Lene Jacobsen for expert technical assistance and Dr. R. J. Kaufman (Genetics Institute, Boston) for the gift of the expression vector pMT2.

    FOOTNOTES

* This study was funded in part by grants from by the Foundation for Research Development of South Africa (to D. B. M. and D. G. W.); the Danish Medical Research Council, the NOVO Nordisk Foundation, Denmark, and the Research Foundation of Aarhus University (to B. V. and J. P. A.); and the Medical Research Council of Canada (to D. H. M.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence may be addressed: Dept. of Chemical Pathology, University of Cape Town Medical School, Observatory, 7925, Cape Town, South Africa. Fax: 27-21-4488150; E-mail: davidmci@ chempath.uct.ac.za.

§ To whom correspondence may be addressed: Dept. of Physiology, University of Aarhus, Ole Worms All 233 160, Universitetsparken, DK8000 Aarhus, C, Denmark. Fax: 45-86-12-90-65; E-mail: jpa@fi. au.dk.

    ABBREVIATIONS

The abbreviations used are: TNP-8N3-ATP, 2',3'-O-(2,4,6-trinitrophenyl)-8-azido-adenosine triphosphate; TNP, trinitrophenyl; AMPPCP, adenylyl beta ,gamma -methylene triphosphate; CrATP, beta ,gamma -bidentate chromium(III) complex of ATP; E1 and E2, major conformational states of Ca2+-ATPase; MOPS, 3-(N-morpholino)propanesulfonic acid; HEPPS, N-2-hydroxyethylpiperazine-N'-3-propanesulfonic acid; HPLC, high pressure liquid chromatography; TES, 2-{[2-hydroxy-1,1-bis(hy-droxymethyl)ethyl]amino}ethanesulfonic acid; TMAH, tetramethyl ammonium hydroxide.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Hasselbach, W., and Makinose, M. (1961) Biochem. Z. 333, 518-528[Medline] [Order article via Infotrieve]
2. MacLennan, D. H., Brandl, C. J., Korzak, B., and Green, N. M. (1985) Nature 316, 696-700[CrossRef][Medline] [Order article via Infotrieve]
3. Levy, D., Seigneuret, M., Bluzat, A., and Rigaud, J-L. (1990) J. Biol. Chem. 265, 19524-19534[Abstract/Free Full Text]
4. Degani, C., and Boyer, P. D. (1973) J. Biol. Chem. 248, 8222-8226[Abstract/Free Full Text]
5. MacLennan, D. H., Rice, W. J., and Green, N. M. (1997) J. Biol. Chem. 272, 28815-28818[Free Full Text]
6. Pedersen, P. A., Rasmussen, J. H., and Jorgensen, P. L. (1996) Biochemistry 35, 16085-16093[CrossRef][Medline] [Order article via Infotrieve]
7. Forge, V., Mintz, E., and Guillain, F. (1993) J. Biol. Chem. 268, 10953-10960[Abstract/Free Full Text]
8. Lacapère, J-J., and Guillain, F. (1993) Eur. J. Biochem. 211, 117-126[Medline] [Order article via Infotrieve]
9. Lacapère, J-J., Bennett, N., Dupont, Y., and Guillain, F. (1990) J. Biol. Chem. 265, 348-353[Abstract/Free Full Text]
10. Pickart, C. M., and Jencks, W. P. (1984) J. Biol. Chem. 259, 1629-1643[Abstract/Free Full Text]
11. Champeil, P., Riollet, S., Orlowski, S., Guillain, F., Seebregts, C. J., and McIntosh, D. B. (1988) J. Biol. Chem. 263, 12288-12294[Abstract/Free Full Text]
12. McIntosh, D. B., and Boyer, P. D. (1983) Biohemistry 22, 2867-2875 [CrossRef][Medline] [Order article via Infotrieve]
13. Andersen, J. P., and Moller, J. V. (1985) Biochim. Biophys. Acta 815, 9-15[Medline] [Order article via Infotrieve]
14. McIntosh, D. B., Woolley, D. G., and Berman, M. C. (1992) J. Biol. Chem. 267, 5301-5309[Abstract/Free Full Text]
15. McIntosh, D. B., and Woolley, D. G. (1994) J. Biol. Chem. 269, 21587-21595[Abstract/Free Full Text]
16. McIntosh, D. B., Woolley, D. G., Vilsen, B., and Andersen, J. P. (1996) J. Biol. Chem. 271, 25778-25789[Abstract/Free Full Text]
17. Green, N. M. (1989) Biochem. Soc. Trans. 17, 970-972
18. Maruyama, K., and MacLennan, D. H. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 3314-3318[Abstract/Free Full Text]
19. Maruyama, K., Clarke, D. M., Fujii, J., Inesi, G., Loo, T. W., and MacLennan, D. H. (1989) J. Biol. Chem. 264, 13038-13042[Abstract/Free Full Text]
20. Kaufman, R. J., Davies, M. V., Pathak, V. K., and Hershey, J. W. B. (1989) Mol. Cell. Biol. 9, 946-958[Abstract/Free Full Text]
21. Vilsen, B., Andersen, J. P., and MacLennan, D. H. (1991) J. Biol. Chem. 266, 16157-16164[Abstract/Free Full Text]
22. Seebregts, C. J., and McIntosh, D. B. (1989) J. Biol. Chem. 264, 2043-2052[Abstract/Free Full Text]
23. Fabiato, A., and Fabiato, F. (1979) J. Physiol. 75, 463-505
24. Vilsen, B., and Andersen, J. P. (1992) J. Biol. Chem. 267, 25739-25743[Abstract/Free Full Text]
25. Serpersu, E. H., Kirch, U., and Schoner, W. (1982) Eur. J. Biochem. 122, 347-354[Medline] [Order article via Infotrieve]
26. Vilsen, B., and Andersen, J. P. (1986) Bochim. Biophys. Acta 855, 429-431 [Medline] [Order article via Infotrieve]
27. Vilsen, B., and Andersen, J. P. (1992) J. Biol. Chem. 267, 3539-3550[Abstract/Free Full Text]
28. Sagara, Y., Wade, J. B., and Inesi, G. (1991) J. Biol. Chem. 267, 1286-1292[Abstract/Free Full Text]
29. Meissner, G. (1973) Biochim. Biophys. Acta 298, 906-926[Medline] [Order article via Infotrieve]
30. Reinstein, J., and Jencks,